Mucocutaneous leishmaniasis: a review of clinical aspects

Dry type leishmanial lymphadenitis presented as two large parotid and cervical masses

“…Lymph node involvement is a well‐recognized manifestation of dry type CL, induced by L. tropica as confirmed by immunological studies 7–14 . Lymph node involvement, in both old and new world CL, 15–18 is frequently mentioned but the finding is generally missed as a complication of secondary bacterial infection. Healed or active CL was noted in 10 of 19 cases of leishmania lymphadenitis without evidence of visceral leishmaniasis reported from Iran 13 .…”

American Cutaneous Leishmaniasis unresponsive to antimonial drugs: successful treatment using combination of N‐Methilglucamine Antimoniate plus Pentoxifylline

“…ACL represents a serious socio‐economical problem, affecting the economically active population and especially, low‐income groups. In endemic areas, it is responsible for the majority of hospitalizations due to dermatological problems 1 .…”

Desenvolvimento e farmacocinética de antimônio encapsulado em lipossomas de fosfatidilserina utilizando radioisótopos em leishmaniose experimental

“…Atualmente, o Pentostam® é manufaturado e comercializado nos países de língua inglesa e na Ásia, enquanto o Glucantime® é manufaturado e comercializado nos países de língua francesa e espanhola e na América Latina. As poucas diferenças entre os dois fármacos estão relacionadas à estabilidade e à toxicidade (Marsden & Nonata, 1975).…”